001     170378
005     20240229133711.0
024 7 _ |a 10.1186/s13058-021-01450-7
|2 doi
024 7 _ |a pmid:34407845
|2 pmid
024 7 _ |a pmc:PMC8371820
|2 pmc
024 7 _ |a 1465-5411
|2 ISSN
024 7 _ |a 1465-542X
|2 ISSN
024 7 _ |a altmetric:112026606
|2 altmetric
037 _ _ |a DKFZ-2021-01887
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Morra, Anna
|b 0
245 _ _ |a Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
260 _ _ |a London
|c 2021
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1638538461_4151
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Given the high heterogeneity among breast tumors, associations between common germline genetic variants and survival that may exist within specific subgroups could go undetected in an unstratified set of breast cancer patients.We performed genome-wide association analyses within 15 subgroups of breast cancer patients based on prognostic factors, including hormone receptors, tumor grade, age, and type of systemic treatment. Analyses were based on 91,686 female patients of European ancestry from the Breast Cancer Association Consortium, including 7531 breast cancer-specific deaths over a median follow-up of 8.1 years. Cox regression was used to assess associations of common germline variants with 15-year and 5-year breast cancer-specific survival. We assessed the probability of these associations being true positives via the Bayesian false discovery probability (BFDP < 0.15).Evidence of associations with breast cancer-specific survival was observed in three patient subgroups, with variant rs5934618 in patients with grade 3 tumors (15-year-hazard ratio (HR) [95% confidence interval (CI)] 1.32 [1.20, 1.45], P = 1.4E-08, BFDP = 0.01, per G allele); variant rs4679741 in patients with ER-positive tumors treated with endocrine therapy (15-year-HR [95% CI] 1.18 [1.11, 1.26], P = 1.6E-07, BFDP = 0.09, per G allele); variants rs1106333 (15-year-HR [95% CI] 1.68 [1.39,2.03], P = 5.6E-08, BFDP = 0.12, per A allele) and rs78754389 (5-year-HR [95% CI] 1.79 [1.46,2.20], P = 1.7E-08, BFDP = 0.07, per A allele), in patients with ER-negative tumors treated with chemotherapy.We found evidence of four loci associated with breast cancer-specific survival within three patient subgroups. There was limited evidence for the existence of associations in other patient subgroups. However, the power for many subgroups is limited due to the low number of events. Even so, our results suggest that the impact of common germline genetic variants on breast cancer-specific survival might be limited.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Breast cancer-specific survival
|2 Other
650 _ 7 |a Common germline genetic variants
|2 Other
650 _ 7 |a Patient subgroups
|2 Other
650 _ 7 |a Systemic treatment
|2 Other
650 _ 7 |a Tumor biology
|2 Other
700 1 _ |a Escala-Garcia, Maria
|b 1
700 1 _ |a Beesley, Jonathan
|b 2
700 1 _ |a Keeman, Renske
|b 3
700 1 _ |a Canisius, Sander
|b 4
700 1 _ |a Ahearn, Thomas U
|b 5
700 1 _ |a Andrulis, Irene L
|b 6
700 1 _ |a Anton-Culver, Hoda
|b 7
700 1 _ |a Arndt, Volker
|0 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
|b 8
|u dkfz
700 1 _ |a Auer, Paul L
|b 9
700 1 _ |a Augustinsson, Annelie
|b 10
700 1 _ |a Beane Freeman, Laura E
|b 11
700 1 _ |a Becher, Heiko
|b 12
700 1 _ |a Beckmann, Matthias W
|b 13
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 14
|u dkfz
700 1 _ |a Bojesen, Stig E
|b 15
700 1 _ |a Bolla, Manjeet K
|b 16
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 17
|u dkfz
700 1 _ |a Brüning, Thomas
|b 18
700 1 _ |a Buys, Saundra S
|b 19
700 1 _ |a Caan, Bette
|b 20
700 1 _ |a Campa, Daniele
|b 21
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 22
|u dkfz
700 1 _ |a Castelao, Jose E
|b 23
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 24
|u dkfz
700 1 _ |a Chanock, Stephen J
|b 25
700 1 _ |a Cheng, Ting-Yuan David
|b 26
700 1 _ |a Clarke, Christine L
|b 27
700 1 _ |a NBCS Collaborators
|b 28
|e Collaboration Author
700 1 _ |a Colonna, Sarah V
|b 29
700 1 _ |a Couch, Fergus J
|b 30
700 1 _ |a Cox, Angela
|b 31
700 1 _ |a Cross, Simon S
|b 32
700 1 _ |a Czene, Kamila
|b 33
700 1 _ |a Daly, Mary B
|b 34
700 1 _ |a Dennis, Joe
|b 35
700 1 _ |a Dörk, Thilo
|b 36
700 1 _ |a Dossus, Laure
|b 37
700 1 _ |a Dunning, Alison M
|b 38
700 1 _ |a Dwek, Miriam
|b 39
700 1 _ |a Eccles, Diana M
|b 40
700 1 _ |a Ekici, Arif B
|b 41
700 1 _ |a Eliassen, A Heather
|b 42
700 1 _ |a Eriksson, Mikael
|b 43
700 1 _ |a Evans, D Gareth
|b 44
700 1 _ |a Fasching, Peter A
|b 45
700 1 _ |a Flyger, Henrik
|b 46
700 1 _ |a Fritschi, Lin
|b 47
700 1 _ |a Gago-Dominguez, Manuela
|b 48
700 1 _ |a García-Sáenz, José A
|b 49
700 1 _ |a Giles, Graham G
|b 50
700 1 _ |a Grip, Mervi
|b 51
700 1 _ |a Guénel, Pascal
|b 52
700 1 _ |a Gündert, Melanie
|0 P:(DE-HGF)0
|b 53
700 1 _ |a Hahnen, Eric
|b 54
700 1 _ |a Haiman, Christopher A
|b 55
700 1 _ |a Håkansson, Niclas
|b 56
700 1 _ |a Hall, Per
|b 57
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 58
|u dkfz
700 1 _ |a Hart, Steven N
|b 59
700 1 _ |a Hartikainen, Jaana M
|b 60
700 1 _ |a Hartmann, Arndt
|b 61
700 1 _ |a He, Wei
|b 62
700 1 _ |a Hooning, Maartje J
|b 63
700 1 _ |a Hoppe, Reiner
|b 64
700 1 _ |a Hopper, John L
|b 65
700 1 _ |a Howell, Anthony
|b 66
700 1 _ |a Hunter, David J
|b 67
700 1 _ |a Investigators, ABCTB
|b 68
|e Collaboration Author
700 1 _ |a Investigators, kConFab
|b 69
|e Collaboration Author
700 1 _ |a Jager, Agnes
|b 70
700 1 _ |a Jakubowska, Anna
|b 71
700 1 _ |a Janni, Wolfgang
|b 72
700 1 _ |a John, Esther M
|b 73
700 1 _ |a Jung, Audrey Y
|0 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
|b 74
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 75
|u dkfz
700 1 _ |a Keupers, Machteld
|b 76
700 1 _ |a Kitahara, Cari M
|b 77
700 1 _ |a Koutros, Stella
|b 78
700 1 _ |a Kraft, Peter
|b 79
700 1 _ |a Kristensen, Vessela N
|b 80
700 1 _ |a Kurian, Allison W
|b 81
700 1 _ |a Lacey, James V
|b 82
700 1 _ |a Lambrechts, Diether
|b 83
700 1 _ |a Le Marchand, Loic
|b 84
700 1 _ |a Lindblom, Annika
|b 85
700 1 _ |a Linet, Martha
|b 86
700 1 _ |a Luben, Robert N
|b 87
700 1 _ |a Lubiński, Jan
|b 88
700 1 _ |a Lush, Michael
|b 89
700 1 _ |a Mannermaa, Arto
|b 90
700 1 _ |a Manoochehri, Mehdi
|0 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
|b 91
|u dkfz
700 1 _ |a Margolin, Sara
|b 92
700 1 _ |a Martens, John W M
|b 93
700 1 _ |a Martinez, Maria Elena
|b 94
700 1 _ |a Mavroudis, Dimitrios
|b 95
700 1 _ |a Michailidou, Kyriaki
|b 96
700 1 _ |a Milne, Roger L
|b 97
700 1 _ |a Mulligan, Anna Marie
|b 98
700 1 _ |a Muranen, Taru A
|b 99
700 1 _ |a Nevanlinna, Heli
|b 100
700 1 _ |a Newman, William G
|b 101
700 1 _ |a Nielsen, Sune F
|b 102
700 1 _ |a Nordestgaard, Børge G
|b 103
700 1 _ |a Olshan, Andrew F
|b 104
700 1 _ |a Olsson, Håkan
|b 105
700 1 _ |a Orr, Nick
|b 106
700 1 _ |a Park-Simon, Tjoung-Won
|b 107
700 1 _ |a Patel, Alpa V
|b 108
700 1 _ |a Peissel, Bernard
|b 109
700 1 _ |a Peterlongo, Paolo
|b 110
700 1 _ |a Plaseska-Karanfilska, Dijana
|b 111
700 1 _ |a Prajzendanc, Karolina
|b 112
700 1 _ |a Prentice, Ross
|b 113
700 1 _ |a Presneau, Nadege
|b 114
700 1 _ |a Rack, Brigitte
|b 115
700 1 _ |a Rennert, Gad
|b 116
700 1 _ |a Rennert, Hedy S
|b 117
700 1 _ |a Rhenius, Valerie
|b 118
700 1 _ |a Romero, Atocha
|b 119
700 1 _ |a Roylance, Rebecca
|b 120
700 1 _ |a Ruebner, Matthias
|b 121
700 1 _ |a Saloustros, Emmanouil
|b 122
700 1 _ |a Sawyer, Elinor J
|b 123
700 1 _ |a Schmutzler, Rita K
|b 124
700 1 _ |a Schneeweiss, Andreas
|b 125
700 1 _ |a Scott, Christopher
|b 126
700 1 _ |a Shah, Mitul
|b 127
700 1 _ |a Smichkoska, Snezhana
|b 128
700 1 _ |a Southey, Melissa C
|b 129
700 1 _ |a Stone, Jennifer
|b 130
700 1 _ |a Surowy, Harald
|b 131
700 1 _ |a Swerdlow, Anthony J
|b 132
700 1 _ |a Tamimi, Rulla M
|b 133
700 1 _ |a Tapper, William J
|b 134
700 1 _ |a Teras, Lauren R
|b 135
700 1 _ |a Terry, Mary Beth
|b 136
700 1 _ |a Tollenaar, Rob A E M
|b 137
700 1 _ |a Tomlinson, Ian
|b 138
700 1 _ |a Troester, Melissa A
|b 139
700 1 _ |a Truong, Thérèse
|b 140
700 1 _ |a Vachon, Celine M
|b 141
700 1 _ |a Wang, Qin
|b 142
700 1 _ |a Hurson, Amber N
|b 143
700 1 _ |a Winqvist, Robert
|b 144
700 1 _ |a Wolk, Alicja
|b 145
700 1 _ |a Ziogas, Argyrios
|b 146
700 1 _ |a Brauch, Hiltrud
|0 P:(DE-HGF)0
|b 147
700 1 _ |a García-Closas, Montserrat
|b 148
700 1 _ |a Pharoah, Paul D P
|b 149
700 1 _ |a Easton, Douglas F
|b 150
700 1 _ |a Chenevix-Trench, Georgia
|b 151
700 1 _ |a Schmidt, Marjanka K
|0 0000-0002-2228-429X
|b 152
700 1 _ |a Børresen-Dale, Anne-Lise
|b 153
700 1 _ |a Sahlberg, Kristine K
|b 154
700 1 _ |a Ottestad, Lars
|b 155
700 1 _ |a Kåresen, Rolf
|b 156
700 1 _ |a Schlichting, Ellen
|b 157
700 1 _ |a Holmen, Marit Muri
|b 158
700 1 _ |a Sauer, Toril
|b 159
700 1 _ |a Haakensen, Vilde
|b 160
700 1 _ |a Engebråten, Olav
|b 161
700 1 _ |a Naume, Bjørn
|b 162
700 1 _ |a Fosså, Alexander
|b 163
700 1 _ |a Kiserud, Cecile E
|b 164
700 1 _ |a Reinertsen, Kristin V
|b 165
700 1 _ |a Helland, Åslaug
|b 166
700 1 _ |a Riis, Margit
|b 167
700 1 _ |a Geisler, Jürgen
|b 168
700 1 _ |a Grenaker Alnæs, Grethe I
|b 169
700 1 _ |a Clarke, Christine
|b 170
700 1 _ |a Marsh, Deborah
|b 171
700 1 _ |a Scott, Rodney
|b 172
700 1 _ |a Baxter, Robert
|b 173
700 1 _ |a Yip, Desmond
|b 174
700 1 _ |a Carpenter, Jane
|b 175
700 1 _ |a Davis, Alison
|b 176
700 1 _ |a Pathmanathan, Nirmala
|b 177
700 1 _ |a Simpson, Peter
|b 178
700 1 _ |a Graham, J Dinny
|b 179
700 1 _ |a Sachchithananthan, Mythily
|b 180
773 _ _ |a 10.1186/s13058-021-01450-7
|g Vol. 23, no. 1, p. 86
|0 PERI:(DE-600)2041618-0
|n 1
|p 86
|t Breast cancer research
|v 23
|y 2021
|x 1465-542X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:170378
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)d023fdf423d87ee6c710e34dd7581fa0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 53
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 58
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 74
|6 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 75
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 91
|6 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 147
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BREAST CANCER RES : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-02-02
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-He78)C071-20160331
|k C071
|l C071 Cancer Survivorship
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 3
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 4
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 5
920 1 _ |0 I:(DE-He78)C080-20160331
|k C080
|l Molekulare Epidemiologie
|x 6
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l B072 Molekulargenetik des Mammakarzinoms
|x 7
920 1 _ |0 I:(DE-He78)B070-20160331
|k B070
|l B070 Funktionelle Genomanalyse
|x 8
920 1 _ |0 I:(DE-He78)TU01-20160331
|k TU01
|l DKTK TU zentral
|x 9
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C071-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C080-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)B070-20160331
980 _ _ |a I:(DE-He78)TU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21